Investigating the effects of DNA demethylation in chemotherapy resistance by ChIP-on-Chip method
dc.authorid | 0000-0002-7300-4075 | |
dc.authorid | 0000-0003-1571-2986 | |
dc.contributor.author | Demirel Kars, Meltem. | |
dc.contributor.author | Koygun, Gözde. | |
dc.date.accessioned | 2020-03-26T20:14:49Z | |
dc.date.available | 2020-03-26T20:14:49Z | |
dc.date.issued | 2019 | |
dc.department | Selçuk Üniversitesi, Teknoloji Fakültesi, Metalurji ve Malzeme Mühendisliği Bölümü | en_US |
dc.description.abstract | OBJECTIVE This study aimed to determine the epigenetic basis of drug resistance mechanisms developed in MCF-7 breast cancer cell line that is resistant to an anticancer agent paclitaxel. Thus, we investigated the effects of the changes in DNA level on gene expression profile and proposed methods of inhibiting resistance by DNA modifications. METHODS We investigated the epigenetic basis of acquired drug resistance in whole genome by comparing chromosome immunoprecipitation in paclitaxel resistant MCF-7 (MCF-7/Pac) cells and in drug-sensitive (MCP-7/S) cells. For this analysis, DNA samples from both cell lines were immunoprecipitated and labeled with Cy3 and Cy5 fluorescent dyes. Hybridization and array scanning was performed with Agilent all-Genome Microarray platform that was designed to detect DNA methylation. Me obtained high-throughput information was analyzed with a bioinformatics analysis program. RESULTS The results showed that demethylation and epigenetic modulation of the DNA regions encoding 90 genes arc significant in the development of multiple drug resistance (MDR) in breast cancer. Some of these genes, ICAM4, COX6B2, ITGB8, SLC39A4, TUBB2C, COL6A1, DAPK1, RUNX3, SLC35F3, and MAP6, are important players in the development of drug resistance and cancer stem cells. CONCLUSION Studies on reversing multidrug resistance can be carried out by DNA modification or methylation of target genes regions on DNA. The results presented in this study may shed light on drug development studies to make DNA modifications. | en_US |
dc.description.sponsorship | Selcuk University BAP project [14401033] | en_US |
dc.description.sponsorship | Selcuk University BAP project (number 14401033). | en_US |
dc.identifier.citation | Kars, M. D., Koygun, G. (2019). Investigating the Effects of DNA Demethylation in Chemotherapy Resistance by Chip-On-Chip Method. Turkish Journal of Oncology, 34(2), 72-80. | |
dc.identifier.doi | 10.5505/tjo.2019.1866 | en_US |
dc.identifier.endpage | 80 | en_US |
dc.identifier.issn | 1300-7467 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | #YOK | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 72 | en_US |
dc.identifier.uri | https://dx.doi.org/10.5505/tjo.2019.1866 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/37941 | |
dc.identifier.volume | 34 | en_US |
dc.identifier.wos | WOS:000469789600003 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.institutionauthor | Koygun, Gözde. | |
dc.language.iso | en | en_US |
dc.publisher | KARE PUBL | en_US |
dc.relation.ispartof | TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Demethylation | en_US |
dc.subject | epigenetics | en_US |
dc.subject | multidrug resistance | en_US |
dc.subject | MDR | en_US |
dc.subject | MCF-7 | en_US |
dc.subject | paclitaxel | en_US |
dc.title | Investigating the effects of DNA demethylation in chemotherapy resistance by ChIP-on-Chip method | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- Meltem DEMİREL KARS.pdf
- Boyut:
- 1.3 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Full Text Access